$31 Profit
SAVALong Stock
Nucleus FDA - Phase 2a data due for Alzheimer’s Disease in Second Half (but possible coming July 14-16 at a conference)
| Date | Price | |
|---|---|---|
| Entry | 7/5/2019 | 1.3891 |
| Exit | 7/5/2019 | 1.4201 |
- Total Views153
- Position Size1,000
- Percentage2.23%
Copy and paste the following into your page or blog. If using WordPress, you must paste this in the HTML tab only:
